Loading...
Recommended Therapeutic INR Range for Patients with Antiphospholipid Syndrome on Warfarin Anticoagulation: Is Moderate-Intensity (INR 2.0 - 3.0) or High-Intensity (INR 3.1 - 4.0) Better for Reducing Risk of Recurrent Thromboembolic Events?
Patients with antiphospholipid syndrome (APS) are at increased risk of recurrent thromboembolic events due to the pathology of the disease. While prolonged anticoagulation is the treatment of choice for patients with thrombosis, much debate remains about the optimum intensity of anticoagulation. Ant...
Na minha lista:
| Udgivet i: | Cureus |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Cureus
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5045335/ https://ncbi.nlm.nih.gov/pubmed/27725921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.765 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|